FDA Inspection 808935 — Medefil Incorporated

Medefil Incorporated — FEI 3001677091

The FDA completed an inspection of Medefil Incorporated on Dec 20, 2012 in Glendale Heights, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 20, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Glendale Heights, IL (United States)

Citations

IDCFRDescription
342621 CFR 820.50(a)(1)Documented evaluation
63121 CFR 803.17(a)(1)Lack of System for Event Evaluations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.